Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A critical function for type I interferons in cancer immunoediting.

Gavin P Dunn1, Allen T Bruce, Kathleen C F Sheehan

  • 1Department of Pathology and Immunology, Center for Immunology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

Nature Immunology
|June 14, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor infiltrating lymphocytes in glioblastoma: immunobiology and translational implications.

NPJ precision oncology·2026
Same author

Automating neoantigen selection for personalized cancer vaccine design.

medRxiv : the preprint server for health sciences·2026
Same author

A modular and flexible pipeline for intraoperative electrode reconstruction and localization in patients with brain lesions.

Frontiers in neural circuits·2026
Same author

Tumoral and Systemic Immune Correlates of Response to Concurrent Pembrolizumab and Chemoradiotherapy in Patients with Resected High-Risk Head and Neck Squamous Cell Carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

IDH1-Associated m6A Methylation Is Linked to Transcriptomic Heterogeneity in Glioma.

Cancers·2026
Same author

High-avidity TCR signaling induces a distinct KLR-positive exhaustion state in human tumor-infiltrating CD8 T cells associated with immunotherapy response.

bioRxiv : the preprint server for biology·2026

Type I interferons (IFN-alpha/beta) are crucial for preventing tumor growth, acting on host hematopoietic cells rather than tumor cells. This highlights their distinct role in cancer immunoediting alongside interferon-gamma (IFN-gamma).

Area of Science:

  • Immunology
  • Oncology
  • Cancer Research

Background:

  • The cancer immunoediting process involves immune surveillance and tumor outgrowth.
  • Interferon-gamma (IFN-gamma) is a known mediator, but the role of type I interferons (IFN-alpha/beta) remains unclear.

Purpose of the Study:

  • To investigate the involvement of type I interferons (IFN-alpha/beta) in cancer immunoediting.
  • To elucidate the cellular targets of type I interferons in antitumor responses.

Main Methods:

  • Studied the impact of endogenous IFN-alpha/beta on primary carcinogen-induced and transplantable tumors.
  • Differentiated between IFN-gamma and IFN-alpha/beta cellular targets in antitumor immunity.

Main Results:

Related Experiment Videos

  • Endogenous type I interferons (IFN-alpha/beta), similar to IFN-gamma, are essential for preventing tumor growth.
  • Host hematopoietic cells, not tumor cells, are the critical targets for type I interferons in antitumor responses.
  • Type I interferons contribute to cancer immunoediting through mechanisms distinct from IFN-gamma.

    • Conclusions:

    • Type I interferons (IFN-alpha/beta) play a significant role in cancer immunoediting.
    • Their mechanism of action involves targeting host hematopoietic cells, complementing IFN-gamma's role.